The
pharmaceuticals industry has played a very crucial role over the past few
years. It has not only generated considerable amounts of employment but has
also opened doors to fields of research in aspects like bio medics, cancer
treatments and other diseases that were considered to be fatal like say, a
decade from today. As a matter of fact, pharmaceuticals industry caters the
development, production, and marketing of medicines .However the locus of
control pharmaceuticals companies have to face is considerably vast. They have
to deal with laws and legislations pertaining to drug manufacture. They cannot
produce drugs that can have severe repercussions on side effects on the
consumers, for example. Similarly, they also have to attain surety of the
quality management systems. This tight locus of control means that all the pharmaceuticals
companies have to be especially particular in the contexts mentioned above.
The
recent times have seen major developments in the pharmaceuticals fields. Owing
to the hard core technological advancements that have taken place over the
decade, we have seen numerous pharmaceuticals firms plummeting as consequence.
The existing ones have expanded their scale of operations in variety of zones
that were not even though of previously. An example, although not directly
related to the pharmaceuticals industry would be that of artificial limbs that
have given hope to countless people who couldn’t have been able to walk after
an accident or amputation because of some reason. Similarly, developments of
‘heart disease-on-a-chip’ by Harvard students have made possible eradication of
any cancerous cells before they begin to expand and harm the human body.
Likewise, the development of a vaccine that improves a person’s immunity system
against harmful viruses have helped people to survive longer against diseases
that were previously taken to be highly fatal and incurable. These recent
developments have highly improved the overall outlook of the pharmaceuticals
industry and have attracted many new scientists into exploring this new world
of medicine.
Speaking
of the major stakeholders in the pharmaceuticals industry, we see that Johnson
& Johnson, Pfizer stock, Novartis,
Rosche and GlaxoSmithKline have been the notable ones. According to recent
statistics, the pharmaceuticals industry is about US$300 billion an year, and
is expected to rise to US$400 billion over the next 3 years. They are majorly
based in the US and the UK. The pharmaceutical company on the whole plays a
positive role in the stock exchange with all the companies listed and trading
attractively on the major stock exchanges all over the globe. For detailed
analysis about the pharmaceutical companies and respective standings, visit
bidnessetc.com.
All
these top notch pharmaceuticals companies have been performing quite well on
the stock exchange. Market trends are supportive of the fact that these
companies have been able to gain investors trust and recognition all over the
globe. Speaking of the market leaders in performance on basis on stock markets,
we see that Johnson & Johnson has been the leader in terms of share prices
with a share price of US$101.2 / share. This is followed by GSK which trades at
US$ 55.2 / share. Pfizer and Rosche on the other hand trade at a low of US$
29.2 / share and US$36.31 / share respectively. A very important aspect that must be taken
into consideration at this point of time is the fact that these share prices
have seen minimal changes in share value over the past few years. According to
sources, they have seen a change of less than 1% over the past few years, which
is very impressive. This not only strengthens the level of trust investors have
on these firms but are also encouraged to invest more, which in turn proves
fruitful for the company’s potential growth. Not enough? Log on to www.bidnessetc.com for more!
